These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 29091898)
1. Protective effect of dioscin against thioacetamide-induced acute liver injury via FXR/AMPK signaling pathway in vivo. Zheng L; Yin L; Xu L; Qi Y; Li H; Xu Y; Han X; Liu K; Peng J Biomed Pharmacother; 2018 Jan; 97():481-488. PubMed ID: 29091898 [TBL] [Abstract][Full Text] [Related]
2. Dioscin alleviates dimethylnitrosamine-induced acute liver injury through regulating apoptosis, oxidative stress and inflammation. Zhang W; Yin L; Tao X; Xu L; Zheng L; Han X; Xu Y; Wang C; Peng J Environ Toxicol Pharmacol; 2016 Jul; 45():193-201. PubMed ID: 27317992 [TBL] [Abstract][Full Text] [Related]
3. Protective effects of dioscin against doxorubicin-induced nephrotoxicity via adjusting FXR-mediated oxidative stress and inflammation. Zhang Y; Xu Y; Qi Y; Xu L; Song S; Yin L; Tao X; Zhen Y; Han X; Ma X; Liu K; Peng J Toxicology; 2017 Mar; 378():53-64. PubMed ID: 28082111 [TBL] [Abstract][Full Text] [Related]
4. Dioscin alleviates lung ischemia/reperfusion injury by regulating FXR-mediated oxidative stress, apoptosis, and inflammation. Dong L; Yin L; Li R; Xu L; Xu Y; Han X; Qi Y Eur J Pharmacol; 2021 Oct; 908():174321. PubMed ID: 34252440 [TBL] [Abstract][Full Text] [Related]
5. Dioscin reduces lipopolysaccharide-induced inflammatory liver injury via regulating TLR4/MyD88 signal pathway. Yao H; Hu C; Yin L; Tao X; Xu L; Qi Y; Han X; Xu Y; Zhao Y; Wang C; Peng J Int Immunopharmacol; 2016 Jul; 36():132-141. PubMed ID: 27135544 [TBL] [Abstract][Full Text] [Related]
6. Protective effects of dioscin against fructose-induced renal damage via adjusting Sirt3-mediated oxidative stress, fibrosis, lipid metabolism and inflammation. Qiao Y; Xu L; Tao X; Yin L; Qi Y; Xu Y; Han X; Tang Z; Ma X; Liu K; Peng J Toxicol Lett; 2018 Mar; 284():37-45. PubMed ID: 29197622 [TBL] [Abstract][Full Text] [Related]
7. Dioscin alleviates lipopolysaccharide-induced inflammatory kidney injury via the microRNA let-7i/TLR4/MyD88 signaling pathway. Qi M; Yin L; Xu L; Tao X; Qi Y; Han X; Wang C; Xu Y; Sun H; Liu K; Peng J Pharmacol Res; 2016 Sep; 111():509-522. PubMed ID: 27431331 [TBL] [Abstract][Full Text] [Related]
8. [Protective effect of water extracts of Orychophragmus violaceus seeds on TAA-induced acute liver injury in mice]. Pang M; Shan Y; Wang FF; Yang SX; Li LY; Cao L Zhongguo Zhong Yao Za Zhi; 2020 Mar; 45(6):1399-1405. PubMed ID: 32281354 [TBL] [Abstract][Full Text] [Related]
9. Protective effects of dioscin against systemic inflammatory response syndromevia adjusting TLR2/MyD88/NF‑κb signal pathway. Zhao X; Yin L; Fang L; Xu L; Sun P; Xu M; Liu K; Peng J Int Immunopharmacol; 2018 Dec; 65():458-469. PubMed ID: 30390593 [TBL] [Abstract][Full Text] [Related]
10. Dioscin alleviates myocardial infarction injury via regulating BMP4/NOX1-mediated oxidative stress and inflammation. Zhang Z; Zhao X; Gao M; Xu L; Qi Y; Wang J; Yin L Phytomedicine; 2022 Aug; 103():154222. PubMed ID: 35675750 [TBL] [Abstract][Full Text] [Related]
11. Hepatoprotection of yangonin against hepatic fibrosis in mice via farnesoid X receptor activation. Wang X; Fu T; Wang J; Wang C; Liu K; Wu J; Sun H; Ma X; Sun P; Meng Q Int Immunopharmacol; 2019 Oct; 75():105833. PubMed ID: 31450152 [TBL] [Abstract][Full Text] [Related]
13. Dioscin alleviates BDL- and DMN-induced hepatic fibrosis via Sirt1/Nrf2-mediated inhibition of p38 MAPK pathway. Gu L; Tao X; Xu Y; Han X; Qi Y; Xu L; Yin L; Peng J Toxicol Appl Pharmacol; 2016 Feb; 292():19-29. PubMed ID: 26747300 [TBL] [Abstract][Full Text] [Related]
14. Protective effects of pentoxifylline on acute liver injury induced by thioacetamide in rats. Luo M; Dong L; Li J; Wang Y; Shang B Int J Clin Exp Pathol; 2015; 8(8):8990-6. PubMed ID: 26464641 [TBL] [Abstract][Full Text] [Related]
15. Dioscin exerts nephroprotective effects by attenuating oxidative stress and necroptosis-induced inflammation. Wang S; Lei Z; Chen S; Xiang A; Zou Y; Liu Y Int Immunopharmacol; 2024 Oct; 140():112885. PubMed ID: 39116496 [TBL] [Abstract][Full Text] [Related]
16. Dioscin attenuates hepatic ischemia-reperfusion injury in rats through inhibition of oxidative-nitrative stress, inflammation and apoptosis. Tao X; Wan X; Xu Y; Xu L; Qi Y; Yin L; Han X; Lin Y; Peng J Transplantation; 2014 Sep; 98(6):604-11. PubMed ID: 25083618 [TBL] [Abstract][Full Text] [Related]
17. Protective effects of dioscin against cisplatin-induced nephrotoxicity via the microRNA-34a/sirtuin 1 signalling pathway. Zhang Y; Tao X; Yin L; Xu L; Xu Y; Qi Y; Han X; Song S; Zhao Y; Lin Y; Liu K; Peng J Br J Pharmacol; 2017 Aug; 174(15):2512-2527. PubMed ID: 28514495 [TBL] [Abstract][Full Text] [Related]
18. Dioscin alleviates non-alcoholic fatty liver disease through adjusting lipid metabolism via SIRT1/AMPK signaling pathway. Yao H; Tao X; Xu L; Qi Y; Yin L; Han X; Xu Y; Zheng L; Peng J Pharmacol Res; 2018 May; 131():51-60. PubMed ID: 29574225 [TBL] [Abstract][Full Text] [Related]
19. Dioscin attenuates gastric ischemia/reperfusion injury through the down-regulation of PKC/ERK1/2 signaling via PKCα and PKCβ2 inhibition. Hu Y; Tao X; Han X; Xu L; Yin L; Qi Y; Zhao Y; Xu Y; Wang C; Peng J Chem Biol Interact; 2016 Oct; 258():234-44. PubMed ID: 27649624 [TBL] [Abstract][Full Text] [Related]
20. Protective Effects of Dioscin Against Doxorubicin-Induced Hepatotoxicity Song S; Chu L; Liang H; Chen J; Liang J; Huang Z; Zhang B; Chen X Front Pharmacol; 2019; 10():1030. PubMed ID: 31572199 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]